Erratum to: Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: results from the ESMaestras cohort (Int J Cancer, (2014), 134, 6, (1436-44), 10.1002/ijc.28469);Circulating concentrations of insulin-like growth factor-I, insulin-like growth factor-binding protein-3, genetic polymorphisms and mammographic density in premenopausal Mexican women: Results from the ESMaestras cohort

International Journal of Cancer

Volumn 134, Issue 6, 2014, Pages 1436-1444

  Rinaldi, S ^a   Biessy, C ^a   Hernandez, M ^a   Lesueur, F ^a,b   Dos Santos Silva, I ^c   Rice, M S ^d,e   Lajous, M ^f   Lopez Ridaura, R ^f   Torres Mejia G ^f   Romieu, I ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b INSERM U900   (France)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

Author keywords

genetic polymorphisms; IGF; mammographic density; Mexican premenopausal women

Indexed keywords

SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADULT; ARTICLE; BODY MASS; BREAST; COHORT ANALYSIS; CROSS-SECTIONAL STUDY; DENSITY; FEMALE; HUMAN; IGF 1 GENE; IGF 1R GENE; IGFBP 3 GENE; MAMMOGRAPHIC DENSITY; MAMMOGRAPHY; MAMMOGRAPHY SYSTEM; MEXICO; PREMENOPAUSE; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84891828439     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.30112     Document Type: Erratum

References (41)

1. McCormack VA, dos-Santos-Silva I,. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006; 15: 1159-69.
2. Becker S, Kaaks R,. Exogenous and endogenous hormones, mammographic density and breast cancer risk: can mammographic density be considered an intermediate marker of risk? Recent Results Cancer Res 2009; 181: 135-57.
3. Stone J, Dite GS, Gunasekara A, et al. The heritability of mammographically dense and nondense breast tissue. Cancer Epidemiol Biomarkers Prev 2006; 15: 612-17.
4. Boyd NF, Dite GS, Stone J, et al. Heritability of mammographic density, a risk factor for breast cancer. N Engl J Med 2002; 347: 886-94.
5. Biong M, Gram IT, Brill I, et al. Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density. BMC Med Genomics 2010; 3: 9.
6. Sachdev D, Yee D,. The IGF system and breast cancer. Endocr Relat Cancer 2001; 8: 197-209.
7. Ellis MJ, Singer C, Hornby A, et al. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer. Breast Cancer Res Treat 1994; 31: 249-61.
8. Wood TL, Yee D,. Introduction: IGFs and IGFBPs in the normal mammary gland and in breast cancer. J Mammary Gland Biol Neoplasia 2000; 5: 1-5.
9. Key TJ, Appleby PN, Reeves GK, et al. Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies. Lancet Oncol 2010; 11: 530-42.
10. Diorio C, Pollak M, Byrne C, et al. Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005; 14: 1065-73.
11. Boyd NF, Martin LJ, Yaffe MJ, et al. Mammographic density: a hormonally responsive risk factor for breast cancer. J Br Menopause Soc 2006; 12: 186-93.
12. Rice MS, Tworoger SS, Rosner BA, et al. Insulin-like growth factor-1, insulin-like growth factor-binding protein-3, growth hormone, and mammographic density in the Nurses' Health Studies. Breast Cancer Res Treat 2012; 136: 805-12.
13. Walker K, Fletcher O, Johnson N, et al. Premenopausal mammographic density in relation to cyclic variations in endogenous sex hormone levels, prolactin, and insulin-like growth factors. Cancer Res 2009; 69: 6490-9.
14. Maskarinec G, Williams AE, Kaaks R,. A cross-sectional investigation of breast density and insulin-like growth factor I. Int J Cancer 2003; 107: 991-6.
15. dos-Santos-Silva I, Johnson N, De Stavola B, et al. The insulin-like growth factor system and mammographic features in premenopausal and postmenopausal women. Cancer Epidemiol Biomarkers Prev 2006; 15: 449-55.
16. Patel AV, Cheng I, Canzian F, et al. IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3). PLoS One 2008; 3: e2578.
17. Chen W, Wang S, Tian T, et al. Phenotypes and genotypes of insulin-like growth factor 1, IGF-binding protein-3 and cancer risk: evidence from 96 studies. Eur J Hum Genet 2009; 17: 1668-75.
18. Canzian F, Cox DG, Setiawan VW, et al. Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium. Hum Mol Genet 2010; 19: 3873-84.
19. Gu F, Schumacher FR, Canzian F, et al. Eighteen insulin-like growth factor pathway genes, circulating levels of IGF-I and its binding protein, and risk of prostate and breast cancer. Cancer Epidemiol Biomarkers Prev 2010; 19: 2877-87.
20. Sarkissyan M, Mishra DK, Wu Y, et al. IGF gene polymorphisms and breast cancer in African-American and Hispanic women. Int J Oncol 2011; 38: 1663-73.
21. Khoury-Shakour S, Lejbkowicz F, Barnett-Griness O, et al. Genetic variation in IGF-1 and breast cancer risk in Ashkenazi carriers and noncarriers of BRCA1/2 mutations. Eur J Cancer Prev 2009; 18: 361-7.
22. Tamimi RM, Cox DG, Kraft P, et al. Common genetic variation in IGF1, IGFBP-1, and IGFBP-3 in relation to mammographic density: a cross-sectional study. Breast Cancer Res 2007; 9: R18.
23. Verheus M, Peeters PH, Kaaks R, et al. Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause. Cancer Epidemiol Biomarkers Prev 2007; 16: 451-7.
24. Verheus M, Maskarinec G, Woolcott CG, et al. IGF1, IGFBP1 and IGFBP3 genes and mammographic density: the Multiethnic Cohort. Int J Cancer 2010; 127: 1115-23.
25. Romieu I, Escamilla-Nunez MC, Sanchez-Zamorano LM, et al. The association between body shape silhouette and dietary pattern among Mexican women. Public Health Nutr 2012; 15: 116-25.
26. Rice MS, Bertrand KA, Lajous M, et al. Body size throughout the life course and mammographic density in Mexican women. Breast Cancer Res Treat 2013; 138: 601-10.
27. Angeles-Llerenas A, Ortega-Olvera C, Perez-Rodriguez E, et al. Moderate physical activity and breast cancer risk: the effect of menopausal status. Cancer Causes Control 2010; 21: 577-86.
28. Boyd NF, Guo H, Martin LJ, et al. Mammographic density and the risk and detection of breast cancer. N Engl J Med 2007; 356: 227-36.
29. Torres-Mejia G, De Stavola B, Allen DS, et al. Mammographic features and subsequent risk of breast cancer: a comparison of qualitative and quantitative evaluations in the Guernsey prospective studies. Cancer Epidemiol Biomarkers Prev 2005; 14: 1052-9.
30. Byng JW, Boyd NF, Fishell E, et al. The quantitative analysis of mammographic densities. Phys Med Biol 1994; 39: 1629-38.
31. Ursin G, Astrahan MA, Salane M, et al. The detection of changes in mammographic densities. Cancer Epidemiol Biomarkers Prev 1998; 7: 43-7.
32. Caboux E, Lallemand C, Ferro G, et al. Sources of pre-analytical variations in yield of DNA extracted from blood samples: analysis of 50,000 DNA samples in EPIC. PLoS One 2012; 7: e39821.
33. Byrne C, Colditz GA, Willett WC, et al. Plasma insulin-like growth factor (IGF) I, IGF-binding protein 3, and mammographic density. Cancer Res 2000; 60: 3744-8.
34. Kaaks R,. Insulin-like growth factor-I and mammographic breast density. Cancer Epidemiol Biomarkers Prev 2005; 14: 3019.
35. Gram IT, Norat T, Rinaldi S, et al. Body mass index, waist circumference and waist-hip ratio and serum levels of IGF-I and IGFBP-3 in European women. Int J Obes (Lond) 2006; 30: 1623-31.
36. Crowe FL, Key TJ, Allen NE, et al. A cross-sectional analysis of the associations between adult height, BMI and serum concentrations of IGF-I and IGFBP-1 -2 and -3 in the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann Hum Biol 2011; 38: 194-202.
37. Calle EE, Kaaks R,. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-91.
38. Faupel-Badger JM, Berrigan D, Ballard-Barbash R, et al. Anthropometric correlates of insulin-like growth factor 1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels by race/ethnicity and gender. Ann Epidemiol 2009; 19: 841-9.
39. D'Aloisio AA, Schroeder JC, North KE, et al. IGF-I and IGFBP-3 polymorphisms in relation to circulating levels among African American and Caucasian women. Cancer Epidemiol Biomarkers Prev 2009; 18: 954-66.
40. Verheus M, McKay JD, Kaaks R, et al. Common genetic variation in the IGF-1 gene, serum IGF-I levels and breast density. Breast Cancer Res Treat 2008; 112: 109-22.
41. Soderqvist G, Isaksson E, Von SB, et al. Proliferation of breast epithelial cells in healthy women during the menstrual cycle. Am J Obstet Gynecol 1997; 176 (1 Part 1): 123-8.